Predictors of Intrahospital Mortality in Older Patients Admitted Due to COVID-19 in the COVID-19 AGEBRU Study
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Brugmann University Hospital
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- All-cause mortality during hospital admission (admission up to discharge time)
Overview
Brief Summary
The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19
Detailed Description
The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations, the negative impact is higher in older people, pointing this population as the most severely affected.
The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 70 Years to — (Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients aged 70 and older
- •Patients admitted to an acute care geriatric unit due to COVID-19
- •Patients with COVID-19 by PCR, serology or CT scan suggestive of this disease
Exclusion Criteria
- •No other demographic or clinical exclusion criteria will be applied
Outcomes
Primary Outcomes
All-cause mortality during hospital admission (admission up to discharge time)
Time Frame: Through study completion, an average of one month.
Vital status was obtained from medical records
Secondary Outcomes
- Prevalence of medical diseases and geriatric syndromes(Through study completion, an average of one month.)
Investigators
Murielle Surquin
Geriatrics Department
Brugmann University Hospital